CWM
AZN icon

Connecticut Wealth Management’s AstraZeneca AZN Stock Holding History

Connecticut Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$459K Hold
2,418
– – 0.02% 247
2026
Q1 		$477K Sell
2,418
-127
-5% -$24.5K 0.02% 236
2025
Q4 		$468K Hold
2,545
– – 0.02% 232
2025
Q3 		$391K Sell
2,545
-35
-1% -$5.3K 0.02% 247
2025
Q2 		$361K Sell
2,580
-59
-2% -$8.27K 0.02% 241
2025
Q1 		$388K Hold
2,639
– – 0.02% 230
2024
Q4 		$346K Sell
2,639
-102
-4% -$14.3K 0.02% 217
2024
Q3 		$427K Sell
2,741
-165
-6% -$26.6K 0.02% 231
2024
Q2 		$453K Sell
2,906
-59
-2% -$8.88K 0.02% 222
2024
Q1 		$402K Sell
2,965
-27
-0.9% -$3.58K 0.02% 239
2023
Q4 		$403K Buy
2,992
+1,319
+79% +$171K 0.02% 232
2023
Q3 		$227K Buy
1,673
+27
+2% +$3.69K 0.02% 269
2023
Q2 		$236K Buy
+1,646
New +$242K 0.02% 232

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM

Connecticut Wealth Management's AZN Position: Q2 2026 in Review

Connecticut Wealth Management held its AstraZeneca (AZN) position steady in Q2 2026 at 2,418 shares worth $459K. The position accounts for 0.02% of the portfolio, ranked #247.

Connecticut Wealth Management first reported a position in AZN in Q2 2023 and has held it in 13 quarters since. The position peaked at $477K in Q1 2026. 700 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Connecticut Wealth Management held 2,418 shares of AstraZeneca worth $459K as of Q2 2026.
  • Connecticut Wealth Management left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.02% of Connecticut Wealth Management's portfolio in Q2 2026, its #247 holding.
  • Connecticut Wealth Management first reported a position in AstraZeneca in Q2 2023 and has held it in 13 quarters since.
  • Connecticut Wealth Management's AstraZeneca position peaked at $477K in Q1 2026.
  • 700 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Connecticut Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.